Gary W. Cole

1.5k total citations
33 papers, 906 citations indexed

About

Gary W. Cole is a scholar working on Dermatology, Epidemiology and Surgery. According to data from OpenAlex, Gary W. Cole has authored 33 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Dermatology, 11 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Gary W. Cole's work include Autoimmune Bullous Skin Diseases (5 papers), Dermatology and Skin Diseases (5 papers) and Nail Diseases and Treatments (4 papers). Gary W. Cole is often cited by papers focused on Autoimmune Bullous Skin Diseases (5 papers), Dermatology and Skin Diseases (5 papers) and Nail Diseases and Treatments (4 papers). Gary W. Cole collaborates with scholars based in United States, United Kingdom and Australia. Gary W. Cole's co-authors include James Stewart, Jeffrey A. Klein, Mark A. Rosen, M. Bahar, R. Skowsky, G P Stricklin, John J. DiGiovanna, David Eilers, Mark F. Naylor and James Kalivas and has published in prestigious journals such as Diabetes Care, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Gary W. Cole

31 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary W. Cole United States 18 388 298 198 143 119 33 906
R.C.D. Staughton United Kingdom 17 328 0.8× 339 1.1× 178 0.9× 165 1.2× 50 0.4× 62 890
G Lorette France 17 369 1.0× 197 0.7× 97 0.5× 233 1.6× 71 0.6× 72 946
Cameron Kennedy United Kingdom 18 563 1.5× 182 0.6× 176 0.9× 112 0.8× 200 1.7× 80 1.1k
C.R. Darley United Kingdom 20 560 1.4× 264 0.9× 71 0.4× 144 1.0× 56 0.5× 56 1.1k
Pier Luca Bencini Italy 22 800 2.1× 322 1.1× 209 1.1× 152 1.1× 80 0.7× 70 1.3k
T. J. Ryan United Kingdom 23 389 1.0× 169 0.6× 399 2.0× 170 1.2× 105 0.9× 80 1.4k
J Bazex France 17 567 1.5× 234 0.8× 71 0.4× 206 1.4× 87 0.7× 126 1.1k
George Kontochristopoulos Greece 20 769 2.0× 259 0.9× 246 1.2× 159 1.1× 137 1.2× 66 1.3k
Jesús Tercedor‐Sánchez Spain 18 378 1.0× 171 0.6× 199 1.0× 188 1.3× 58 0.5× 102 962
S. Menni Italy 17 401 1.0× 365 1.2× 88 0.4× 251 1.8× 46 0.4× 75 912

Countries citing papers authored by Gary W. Cole

Since Specialization
Citations

This map shows the geographic impact of Gary W. Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary W. Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary W. Cole more than expected).

Fields of papers citing papers by Gary W. Cole

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary W. Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary W. Cole. The network helps show where Gary W. Cole may publish in the future.

Co-authorship network of co-authors of Gary W. Cole

This figure shows the co-authorship network connecting the top 25 collaborators of Gary W. Cole. A scholar is included among the top collaborators of Gary W. Cole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary W. Cole. Gary W. Cole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Jihong, Vijay Suresh Akhade, Joshua Bridgers, et al.. (2025). Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm. Leukemia. 39(4). 917–928.
2.
Weinstock, Martin A., Stephen F. Bingham, John J. DiGiovanna, et al.. (2012). Tretinoin and the Prevention of Keratinocyte Carcinoma (Basal and Squamous Cell Carcinoma of the Skin): A Veterans Affairs Randomized Chemoprevention Trial. Journal of Investigative Dermatology. 132(6). 1583–1590. 72 indexed citations
3.
Murase, Jenny E., Jashin J. Wu, Ivan Théate, et al.. (2009). Bortezomib-induced histiocytoid Sweet syndrome. Journal of the American Academy of Dermatology. 60(3). 496–497. 30 indexed citations
4.
Weinstock, Martin A., S Bingham, Gary W. Cole, et al.. (2001). Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial.. PubMed. 137(8). 1055–8. 67 indexed citations
5.
Segal, Jack L., et al.. (1996). Reversal of Erythema Multiforme Major with Cyclophosphamide and Prednisone. Annals of Pharmacotherapy. 30(6). 606–607. 10 indexed citations
6.
Gooch, W M, Gary W. Cole, Ronald K. Binder, et al.. (1991). Clinical Comparison of Cefuroxime Axetil, Cephalexin and Cefadroxil in the Treatment of Patients with Primary Infections of the Skin or Skin Structures. Dermatology. 183(1). 36–43. 14 indexed citations
7.
Stewart, James, et al.. (1990). Neutralized Lidocaine with Epinephrine for Local Anesthesia — II. The Journal of Dermatologic Surgery and Oncology. 16(9). 842–845. 45 indexed citations
8.
Stewart, James, Gary W. Cole, & Jeffrey A. Klein. (1989). Neutralized Lidocaine with Epinephrine for Local Anesthesia. The Journal of Dermatologic Surgery and Oncology. 15(10). 1081–1088. 83 indexed citations
9.
Cole, Gary W.. (1989). A Comparison of a New Oral Antifungal, Terbinafine, With Griseofulvin as Therapy for Tinea Corporis. Archives of Dermatology. 125(11). 1537–1537. 27 indexed citations
10.
Cole, Gary W. & G P Stricklin. (1989). A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis.. PubMed. 125(11). 1537–9. 30 indexed citations
11.
Cole, Gary W.. (1988). The Measurement of the Volume of Leg Ulcers. The Journal of Dermatologic Surgery and Oncology. 14(4). 421–423. 3 indexed citations
12.
Cole, Gary W., et al.. (1988). The effect of topical cyclosporin A on the elicitation phase of allergic contact dermatitis. Contact Dermatitis. 19(2). 129–132. 13 indexed citations
13.
Cole, Gary W., et al.. (1988). Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent.. PubMed. 42(5). 480–5. 35 indexed citations
14.
Cole, Gary W. & Ronald J. Barr. (1987). Hypomelanosis Associated with a Colonic Abnormality. American Journal of Dermatopathology. 9(1). 45–50. 3 indexed citations
15.
Cole, Gary W.. (1986). The Adherence of Staphylococcus aureus to Human Corneocytes. Archives of Dermatology. 122(2). 166–166. 84 indexed citations
16.
Jegasothy, Brian V., Coleman Jacobson, Norman Levine, et al.. (1985). Clobetasol Propionate Versus Fluocinonide Creams in Psoriasis and Eczema. International Journal of Dermatology. 24(7). 461–465. 31 indexed citations
17.
Katz, H. Irving, et al.. (1984). SCH 370 (clotrimazole-betamethasone dipropionate) cream in patients with tinea cruris or tinea corporis.. PubMed. 34(2). 183–8. 17 indexed citations
18.
Cole, Gary W., et al.. (1983). Scleredema Diabeticorum: A Common and Distinct Cutaneous Manifestation of Diabetes Mellitus. Diabetes Care. 6(2). 189–192. 62 indexed citations
19.
Cole, Gary W.. (1982). An Elastic Tissue Defect in Dermatofibrosis Lenticularis Disseminata. Archives of Dermatology. 118(1). 44–44. 15 indexed citations
20.
Cole, Gary W.. (1977). Secondary Syphilis Presenting as a Pruritic Dermatosis. Archives of Dermatology. 113(4). 489–489. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026